PPP1R12A and neoplasm: The function of MYPT1 overexpression and its implication in cortical mechanics has yet to be characterized in PDAC tumor cells, but its discovery through this immunotherapy clinical trial is a harbinger for the interconnectedness of the individual tumor cell cytoskeleton, immune cells of the tumor microenvironment, and therapeutic responses (60–62).